<?xml version="1.0" encoding="UTF-8" standalone="yes"?>
<References xsi:schemaLocation="http://www.iedb.org/schema/CurationSchema http://beta.iedb.org/schema/Curation.xsd" xmlns="http://www.iedb.org/schema/CurationSchema" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance">
    <Reference>
        <ReferenceId>756</ReferenceId>
        <DateLastUpdated>2020-09-10-07:00</DateLastUpdated>
        <Article>
            <PubmedId>9427737</PubmedId>
            <Abstract>Each T cell receptor (TCR) recognizes a peptide antigen bound to a major histocompatibility complex (MHC) molecule via a clonotypic alphabeta heterodimeric structure (Ti) non-covalently associated with the monomorphic CD3 signaling components. A crystal structure of an alphabeta TCR-anti-TCR Fab complex shows an Fab fragment derived from the H57 monoclonal antibody (mAb), interacting with the elongated FG loop of the Cbeta domain, situated beneath the Vbeta domain. This loop, along with the partially exposed ABED beta sheet of Cbeta, and glycans attached to both Cbeta and Calpha domains, forms a cavity of sufficient size to accommodate a single non-glycosylated Ig domain such as the CD3epsilon ectodomain. That this asymmetrically localized site is embedded within the rigid constant domain module has implications for the mechanism of signal transduction in both TCR and pre-TCR complexes. Furthermore, quaternary structures of TCRs vary significantly even when they bind the same MHC molecule, as manifested by a unique twisting of the V module relative to the C module.</Abstract>
            <ArticleYear>1998</ArticleYear>
            <ArticlePages>10-26</ArticlePages>
            <ArticleTitle>Atomic structure of an alphabeta T cell receptor (TCR) heterodimer in complex with an anti-TCR fab fragment derived from a mitogenic antibody.</ArticleTitle>
            <Authors>
                <Author>
                    <LastName>Wang</LastName>
                    <ForeName>J</ForeName>
                </Author>
                <Author>
                    <LastName>Lim</LastName>
                    <ForeName>K</ForeName>
                </Author>
                <Author>
                    <LastName>Smolyar</LastName>
                    <ForeName>A</ForeName>
                </Author>
                <Author>
                    <LastName>Teng</LastName>
                    <ForeName>M</ForeName>
                </Author>
                <Author>
                    <LastName>Liu</LastName>
                    <ForeName>J</ForeName>
                </Author>
                <Author>
                    <LastName>Tse</LastName>
                    <ForeName>A G</ForeName>
                </Author>
                <Author>
                    <LastName>Liu</LastName>
                    <ForeName>J</ForeName>
                </Author>
                <Author>
                    <LastName>Hussey</LastName>
                    <ForeName>R E</ForeName>
                </Author>
                <Author>
                    <LastName>Chishti</LastName>
                    <ForeName>Y</ForeName>
                </Author>
                <Author>
                    <LastName>Thomson</LastName>
                    <ForeName>C T</ForeName>
                </Author>
                <Author>
                    <LastName>Sweet</LastName>
                    <ForeName>R M</ForeName>
                </Author>
                <Author>
                    <LastName>Nathenson</LastName>
                    <ForeName>S G</ForeName>
                </Author>
                <Author>
                    <LastName>Chang</LastName>
                    <ForeName>H C</ForeName>
                </Author>
                <Author>
                    <LastName>Sacchettini</LastName>
                    <ForeName>J C</ForeName>
                </Author>
                <Author>
                    <LastName>Reinherz</LastName>
                    <ForeName>E L</ForeName>
                </Author>
            </Authors>
            <Affiliations>Laboratory of Immunobiology, Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA 02115, USA.</Affiliations>
            <ArticleChemicalList>CD3 Complex;Immunoglobulin Fab Fragments;Mitogens;Receptors, Antigen, T-Cell, alpha-beta</ArticleChemicalList>
            <ArticleMeshHeadingsList>Amino Acid Sequence; Animals; CD3 Complex(immunology); Crystallography, X-Ray; Humans; Immunoglobulin Fab Fragments(chemistry; immunology); Mice; Mitogens(immunology); Molecular Sequence Data; Protein Conformation; Receptors, Antigen, T-Cell, alpha-beta(chemistry; immunology); Sequence Homology, Amino Acid; Signal Transduction</ArticleMeshHeadingsList>
            <Journal>
                <Volume>17</Volume>
                <Issue>1</Issue>
                <Title>The EMBO journal</Title>
                <Issn>0261-4189</Issn>
                <MedlineTa>EMBO J</MedlineTa>
            </Journal>
        </Article>
        <Epitopes>
            <Epitope>
                <EpitopeName>H57 epitope on β-chain on N15 TCR, epitope A</EpitopeName>
                <EpitopeStructure>
                    <DiscontinuousRegionOnAccessionSequenceMolecule>
                        <ChemicalType>Discontinuous protein residues</ChemicalType>
                        <DiscontinuousResidues>E14, D114, R116, E213, D215, K216, P218, E219, G220, S221, P222</DiscontinuousResidues>
                        <SourceMolecule>
                            <GenBankId>1NFD_B</GenBankId>
                        </SourceMolecule>
                        <SourceOrganismId>10090</SourceOrganismId>
                    </DiscontinuousRegionOnAccessionSequenceMolecule>
                </EpitopeStructure>
                <LocationOfData>Table IV</LocationOfData>
                <EpitopeId>175435</EpitopeId>
                <ReferenceRegion>E14, D118, R120, E221, D223, K224, P226, E227, G228, S229, P230</ReferenceRegion>
                <EpitopeEvidenceCode>Representative selection</EpitopeEvidenceCode>
                <EpitopeStructureDefines>Exact Epitope</EpitopeStructureDefines>
                <Assays>
                    <BCell>
                        <LocationOfData>Tables I, III, IV, Figures 1, 7 and PDB 1NFD</LocationOfData>
                        <BCellId>1511682</BCellId>
                        <Immunization>
                            <HostOrganism>
                                <OrganismId>10032</OrganismId>
                                <Sex>F</Sex>
                            </HostOrganism>
                            <FirstInVivoProcess>
                                <InVivoProcessType>Administration in vivo</InVivoProcessType>
                                <ImmunogenObject>
                                    <EpitopeRelation>Other Structure from Source Organism</EpitopeRelation>
                                    <Object>
                                        <AccessionSequenceMolecule>
                                            <ChemicalType>Protein</ChemicalType>
                                            <Molecule>
                                                <GenBankId>AAA40240.1</GenBankId>
                                            </Molecule>
                                            <SourceOrganismId>10090</SourceOrganismId>
                                        </AccessionSequenceMolecule>
                                    </Object>
                                </ImmunogenObject>
                                <ImmunogenReferenceName>DO-11.10 TCR</ImmunogenReferenceName>
                                <ImmunogenEvidenceCode>Representative selection</ImmunogenEvidenceCode>
                                <Adjuvant>Freund's complete</Adjuvant>
                                <Adjuvant>Freund's incomplete (IFA)</Adjuvant>
                                <Route>Subcutaneous (s.c.)</Route>
                                <DoseSchedule>Multiple doses of 2-5 µg at 2- to 4-week intervals</DoseSchedule>
                            </FirstInVivoProcess>
                            <ImmunizationComments>Generation of the monoclonal antibody was previously described in the cited reference: Kubo et al. (1989) J Immunol 142(8): 2736-2742 [PMID: 2467936]. Hamsters were immunized with affinity-purified DO-11.10 TCR. (The Genbank accession numbers for the alpha and beta chains are representative sequences and not exact matches to DO-11.10). The DO-11.10 TCR is specific for an ovalbumin peptide presented by H-2IAd. The mAb reacts with surface receptors on all alpha beta TCR-bearing cells and in an immobilized form, this antibody can directly activate T cells bearing alpha beta TCR.</ImmunizationComments>
                        </Immunization>
                        <AssayInformation>
                            <AssayTypeId>436</AssayTypeId>
                            <QualitativeMeasurement>Positive</QualitativeMeasurement>
                            <QuantitativeMeasurement>2.8</QuantitativeMeasurement>
                            <MeasurementInequality>=</MeasurementInequality>
                            <AssayComments>The epitope of the H57 anti-TCR Fab on the TCR beta chain was determined from the crystal structure of the complex. The crystal contains two complexes within a single asymmetric unit: complex A with TCR α-chain (chain A), β-chain (chain B), H57 Fab heavy chain (F), light chain (E); and complex B with TCR α-chain (chain C), β-chain (chain D), H57 Fab heavy chain (H), light chain (G). Each Fab molecule binds to the β-chain of N15 TCR using nearly the same interacting residues in a given pair, but with significantly different overall orientation. This finding implies that the same immune receptor may dock somewhat variably to a single ligand and that slight differences in the binding interaction can result in rather large rotations at the distal C region of the Fab "lever arm".</AssayComments>
                        </AssayInformation>
                        <AssayedAntibody>
                            <AssayedAntibodySourceMaterial>Purified Immunoglobulin</AssayedAntibodySourceMaterial>
                            <AssayedAntibodyImmunoglobulinDomain>Fab</AssayedAntibodyImmunoglobulinDomain>
                            <AssayedAntibodyPurificationStatus>Monoclonal</AssayedAntibodyPurificationStatus>
                            <AssayedAntibodyName>H57 anti-TCR</AssayedAntibodyName>
                            <AssayedAntibodyHeavyChainType>IgG</AssayedAntibodyHeavyChainType>
                            <AssayedAntibodyLightChainType>Lambda</AssayedAntibodyLightChainType>
                            <AssayedAntibodyObject>
                                <MultiChainMolecule>
                                    <ChemicalType>Multi-Chain protein</ChemicalType>
                                    <MoleculeName>H57</MoleculeName>
                                    <Chain1>
                                        <Molecule>
                                            <GenBankId>1NFD_H</GenBankId>
                                        </Molecule>
                                        <SourceOrganismId>10090</SourceOrganismId>
                                    </Chain1>
                                    <Chain2>
                                        <Molecule>
                                            <GenBankId>1NFD_G</GenBankId>
                                        </Molecule>
                                        <SourceOrganismId>10090</SourceOrganismId>
                                    </Chain2>
                                </MultiChainMolecule>
                            </AssayedAntibodyObject>
                        </AssayedAntibody>
                        <Antigen>
                            <AntigenReferenceName>N15 TCR</AntigenReferenceName>
                            <AntigenConformation>Native</AntigenConformation>
                            <AntigenObject>
                                <EpitopeRelation>Other Structure from Source Organism</EpitopeRelation>
                                <Object>
                                    <MultiChainMolecule>
                                        <ChemicalType>Multi-Chain protein</ChemicalType>
                                        <MoleculeName>αβ N15 TCR</MoleculeName>
                                        <Chain1>
                                            <Molecule>
                                                <GenBankId>1NFD_A</GenBankId>
                                            </Molecule>
                                            <SourceOrganismId>10090</SourceOrganismId>
                                        </Chain1>
                                        <Chain2>
                                            <Molecule>
                                                <GenBankId>1NFD_B</GenBankId>
                                            </Molecule>
                                            <SourceOrganismId>10090</SourceOrganismId>
                                        </Chain2>
                                    </MultiChainMolecule>
                                </Object>
                            </AntigenObject>
                            <AntigenEvidenceCode>Exact match to reference information</AntigenEvidenceCode>
                        </Antigen>
                        <ThreeDimensionalStructureOfComplex>
                            <ComplexPdbId>1NFD</ComplexPdbId>
                            <AntibodyChain1PdbChain>F</AntibodyChain1PdbChain>
                            <AntibodyChain2PdbChain>E</AntibodyChain2PdbChain>
                            <AntigenChainPdbChain>AB</AntigenChainPdbChain>
                            <ViewerFlag>Y</ViewerFlag>
                            <CuratedContacts>
                                <EpitopeResidues>B: E14, D118, R120, E221, D223, K224, P226, E227, G228, S229, P230;</EpitopeResidues>
                                <AntibodyResiduesInteractingWithAntigen>E: L28:L1, K30:L1, N31:L1, F32:L1, Y34:L1, M50:L2, D51:L2, K53:L2, N95A:L3; F: W33:H1, Y35:H1, R50:H2, N53:H2, A95:H3, G96:H3, R97:H3, F98:H3, H100:H3;</AntibodyResiduesInteractingWithAntigen>
                                <ContactAreaForAntigen>720.0</ContactAreaForAntigen>
                                <ContactAreaForAntibody>740.0</ContactAreaForAntibody>
                            </CuratedContacts>
                            <CalculatedContacts>
                                <EpitopeResidues>B: E14, D118, R120, E221, D223, K224, P226, E227, G228, S229, P230, X249</EpitopeResidues>
                                <AntibodyResiduesInteractingWithAntigen>E: L28, P29, K30, N31, F32, Y34, Y49, M50, D51, K53, N95A; F: W33, Y35, R50, N53, A95, G96, R97, F98, H100</AntibodyResiduesInteractingWithAntigen>
                                <ContactAreaForAntigen>897.5</ContactAreaForAntigen>
                                <ContactAreaForAntibody>792.4</ContactAreaForAntibody>
                            </CalculatedContacts>
                        </ThreeDimensionalStructureOfComplex>
                    </BCell>
                </Assays>
            </Epitope>
            <Epitope>
                <EpitopeName>H57 epitope on β-chain on N15 TCR, epitope B</EpitopeName>
                <EpitopeStructure>
                    <DiscontinuousRegionOnAccessionSequenceMolecule>
                        <ChemicalType>Discontinuous protein residues</ChemicalType>
                        <DiscontinuousResidues>E14, D114, R116, N117, T119, K216, W217, P218, E219, G220, S221, P222</DiscontinuousResidues>
                        <SourceMolecule>
                            <GenBankId>1NFD_B</GenBankId>
                        </SourceMolecule>
                        <SourceOrganismId>10090</SourceOrganismId>
                    </DiscontinuousRegionOnAccessionSequenceMolecule>
                </EpitopeStructure>
                <LocationOfData>Table IV</LocationOfData>
                <EpitopeId>175675</EpitopeId>
                <ReferenceRegion>E14, D118, R120, N121, T123, K224, W225, P226, E227, G228, S229, P230</ReferenceRegion>
                <EpitopeEvidenceCode>Representative selection</EpitopeEvidenceCode>
                <EpitopeStructureDefines>Exact Epitope</EpitopeStructureDefines>
                <Assays>
                    <BCell>
                        <LocationOfData>Tables I, III, IV, Figures 1, 7 and PDB 1NFD</LocationOfData>
                        <BCellId>1511683</BCellId>
                        <Immunization>
                            <HostOrganism>
                                <OrganismId>10032</OrganismId>
                                <Sex>F</Sex>
                            </HostOrganism>
                            <FirstInVivoProcess>
                                <InVivoProcessType>Administration in vivo</InVivoProcessType>
                                <ImmunogenObject>
                                    <EpitopeRelation>Other Structure from Source Organism</EpitopeRelation>
                                    <Object>
                                        <AccessionSequenceMolecule>
                                            <ChemicalType>Protein</ChemicalType>
                                            <Molecule>
                                                <GenBankId>AAA40240.1</GenBankId>
                                            </Molecule>
                                            <SourceOrganismId>10090</SourceOrganismId>
                                        </AccessionSequenceMolecule>
                                    </Object>
                                </ImmunogenObject>
                                <ImmunogenReferenceName>DO-11.10 TCR</ImmunogenReferenceName>
                                <ImmunogenEvidenceCode>Representative selection</ImmunogenEvidenceCode>
                                <Adjuvant>Freund's complete</Adjuvant>
                                <Adjuvant>Freund's incomplete (IFA)</Adjuvant>
                                <Route>Subcutaneous (s.c.)</Route>
                                <DoseSchedule>Multiple doses of 2-5 µg at 2- to 4-week intervals</DoseSchedule>
                            </FirstInVivoProcess>
                            <ImmunizationComments>Generation of the monoclonal antibody was previously described in the cited reference: Kubo et al. (1989) J Immunol 142(8): 2736-2742 [PMID: 2467936]. Hamsters were immunized with affinity-purified DO-11.10 TCR. (The Genbank accession numbers for the alpha and beta chains are representative sequences and not exact matches to DO-11.10). The DO-11.10 TCR is specific for an ovalbumin peptide presented by H-2IAd. The mAb reacts with surface receptors on all alpha beta TCR-bearing cells and in an immobilized form, this antibody can directly activate T cells bearing alpha beta TCR.</ImmunizationComments>
                        </Immunization>
                        <AssayInformation>
                            <AssayTypeId>436</AssayTypeId>
                            <QualitativeMeasurement>Positive</QualitativeMeasurement>
                            <QuantitativeMeasurement>2.8</QuantitativeMeasurement>
                            <MeasurementInequality>=</MeasurementInequality>
                            <AssayComments>The crystal contains two complexes within a single asymmetric unit: complex A with TCR α-chain (chain A), β-chain (chain B), H57 Fab heavy chain (F), light chain (E); and complex B with TCR α-chain (chain C), β-chain (D), H57 Fab heavy chain (H), light chain (G). Each Fab molecule binds to the β-chain of N15 TCR using nearly the same interacting residues in a given pair, but with significantly different overall orientation. This finding implies that the same immune receptor may dock somewhat variably to a single ligand and that light differences in the binding interaction can result in rather large rotations at the distal C region of the Fab "lever arm".</AssayComments>
                        </AssayInformation>
                        <AssayedAntibody>
                            <AssayedAntibodySourceMaterial>Purified Immunoglobulin</AssayedAntibodySourceMaterial>
                            <AssayedAntibodyImmunoglobulinDomain>Fab</AssayedAntibodyImmunoglobulinDomain>
                            <AssayedAntibodyPurificationStatus>Monoclonal</AssayedAntibodyPurificationStatus>
                            <AssayedAntibodyName>H57 anti-TCR</AssayedAntibodyName>
                            <AssayedAntibodyHeavyChainType>IgG</AssayedAntibodyHeavyChainType>
                            <AssayedAntibodyLightChainType>Lambda</AssayedAntibodyLightChainType>
                            <AssayedAntibodyObject>
                                <MultiChainMolecule>
                                    <ChemicalType>Multi-Chain protein</ChemicalType>
                                    <MoleculeName>H57</MoleculeName>
                                    <Chain1>
                                        <Molecule>
                                            <GenBankId>1NFD_H</GenBankId>
                                        </Molecule>
                                        <SourceOrganismId>10090</SourceOrganismId>
                                    </Chain1>
                                    <Chain2>
                                        <Molecule>
                                            <GenBankId>1NFD_G</GenBankId>
                                        </Molecule>
                                        <SourceOrganismId>10090</SourceOrganismId>
                                    </Chain2>
                                </MultiChainMolecule>
                            </AssayedAntibodyObject>
                        </AssayedAntibody>
                        <Antigen>
                            <AntigenReferenceName>N15 TCR</AntigenReferenceName>
                            <AntigenConformation>Native</AntigenConformation>
                            <AntigenObject>
                                <EpitopeRelation>Other Structure from Source Organism</EpitopeRelation>
                                <Object>
                                    <MultiChainMolecule>
                                        <ChemicalType>Multi-Chain protein</ChemicalType>
                                        <MoleculeName>αβ N15 TCR</MoleculeName>
                                        <Chain1>
                                            <Molecule>
                                                <GenBankId>1NFD_A</GenBankId>
                                            </Molecule>
                                            <SourceOrganismId>10090</SourceOrganismId>
                                        </Chain1>
                                        <Chain2>
                                            <Molecule>
                                                <GenBankId>1NFD_B</GenBankId>
                                            </Molecule>
                                            <SourceOrganismId>10090</SourceOrganismId>
                                        </Chain2>
                                    </MultiChainMolecule>
                                </Object>
                            </AntigenObject>
                            <AntigenEvidenceCode>Exact match to reference information</AntigenEvidenceCode>
                        </Antigen>
                        <ThreeDimensionalStructureOfComplex>
                            <ComplexPdbId>1NFD</ComplexPdbId>
                            <AntibodyChain1PdbChain>H</AntibodyChain1PdbChain>
                            <AntibodyChain2PdbChain>G</AntibodyChain2PdbChain>
                            <AntigenChainPdbChain>CD</AntigenChainPdbChain>
                            <ViewerFlag>Y</ViewerFlag>
                            <CuratedContacts>
                                <EpitopeResidues>D: E14, D118, R120, N121, T123, K224, W225, P226, E227, G228, S229, P230;</EpitopeResidues>
                                <AntibodyResiduesInteractingWithAntigen>G: L28:L1, P29:L1, N31:L1, F32:L1, Y34:L1, M50:L2, D51:L2, K53:L2, S91:L3, N95A:L3; H: W33:H1, Y35:H1, R50:H2, N53:H2, A95:H3, G96:H3, R97:H3, F98:H3, H100:H3;</AntibodyResiduesInteractingWithAntigen>
                                <ContactAreaForAntigen>720.0</ContactAreaForAntigen>
                                <ContactAreaForAntibody>740.0</ContactAreaForAntibody>
                            </CuratedContacts>
                            <CalculatedContacts>
                                <EpitopeResidues>D: E14, D118, R120, N121, T123, D223, K224, W225, P226, E227, G228, S229, P230, X249</EpitopeResidues>
                                <AntibodyResiduesInteractingWithAntigen>G: L28, P29, K30, N31, F32, Y34, Y49, M50, D51, K53, S91, N95A, L96; H: W33, Y35, R50, N53, A95, G96, R97, F98, H100</AntibodyResiduesInteractingWithAntigen>
                                <ContactAreaForAntigen>785.5</ContactAreaForAntigen>
                                <ContactAreaForAntibody>721.6</ContactAreaForAntibody>
                            </CalculatedContacts>
                        </ThreeDimensionalStructureOfComplex>
                    </BCell>
                </Assays>
            </Epitope>
        </Epitopes>
    </Reference>
</References>

